BPG is committed to discovery and dissemination of knowledge
Expert Consensus
©The Author(s) 2026.
World J Transplant. Mar 18, 2026; 16(1): 114367
Published online Mar 18, 2026. doi: 10.5500/wjt.v16.i1.114367
Figure 5
Figure 5 Factors influencing the choice of induction therapy. HLA: Human leukocyte antigen; KDIGO: Kidney Disease: Improving Global Outcomes.

  • Citation: Kute VB, Balwani MR, Shrimali JB, Pasari A, Kher V, Patel MP, Chafekar D, Guditi S, Das P, Siddaiah GM, Godara SM, Bhargava V, Gupta A, Ramteke V, Deshpande N, Tolani P, Prasad N, Patil RK, Mohanka R, Mahajan S, Sharma S, Banerjee S, Engineer DP, Agarwal D, Kashiv P, Lahiri A, Khullar D, Srivastava A. Induction therapy in kidney transplant recipients: A consensus statement of Indian Society of Organ Transplantation. World J Transplant 2026; 16(1): 114367
  • URL: https://www.wjgnet.com/2220-3230/full/v16/i1/114367.htm
  • DOI: https://dx.doi.org/10.5500/wjt.v16.i1.114367

Write to the Help Desk